Marea Therapeutics doses first patient in MAR002 phase 2 trial

Teledyne delivers infrared sensors for U.S. missile defense

Investing.com · News 2m ago

CAMINUS to manufacture Amprius battery cells in Indianapolis

Investing.com · News 2m ago

Comtech appoints Christopher Maloney to board of directors

Investing.com · News 2m ago

Ardelyx to present hyperphosphatemia research at ASN meeting

Investing.com · News 2m ago

vTv Therapeutics completes Phase 3 enrollment for T1D drug

Investing.com · News 2m ago

Russia plague: What we know about the suspected case reportedly linked to a lab worker’s death

CNBC · Markets 6m ago

Russia plague: What we know about the suspected case reportedly linked to a lab worker’s death

CNBC · Economy 6m ago

Nvidia's $6-trillion milestone looms. Here's when options traders see it happening

CNBC · Economy 9m ago

Wedbush initiates Korsana Biosciences stock with outperform rating

Investing.com · News 14m ago

BofA starts bullish coverage on NKT on rising HVDC cable demand

Investing.com · News 16m ago